Top Markets
Coin of the day
Rapid Therapeutic Science Laboratories, Inc. Rapid Therapeutic Science Laboratories, Inc.

Rapid Therapeutic Science Laboratories, Inc.

RTSL
Κατάταξη σε μετοχές #42555
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm... Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, including chronic pain, post-traumatic stress disorder (PTSD), insomnia, and aiding in surgery recovery, among other health issues. RTSL's product portfolio features pressurized meter dose inhalers (MDIs), designed to precisely dispense an aerosolized mist into the lungs, alongside sublingual oral spray devices. Furthermore, the company offers water-soluble cannabidiol (CBD) and cannabigerol (CBG) isolates under its "nhaler" brand. Established in 2013 and based in Dallas, Texas, the company adopted its current name, Rapid Therapeutic Science Laboratories, Inc., in January 2020, having previously operated as Holly Brothers Pictures, Inc. It was also formerly a subsidiary of Texas Mdi, Inc.
Τιμή μετοχής
$0.0001
Τελευταίος συγχρονισμός: 2026-08-11
Κεφαλαιοποίηση
$883.00
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
-96.67%
Χώρα
US
Εμπόριο Rapid Therapeutic Science Laboratories, Inc. (RTSL)

Κατηγορία

Ιστορικό τιμής μετοχής για την Rapid Therapeutic Science Laboratories, Inc. (RTSL)
Υψηλότερη τιμή κλεισίματος: $0.00 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $0.85 στις 2017-06-01
Ιστορικό τιμής μετοχής της Rapid Therapeutic Science Laboratories, Inc. από 2017 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) 0.00%
2025 55.30%
2024 -75.53%
2023 -99.59%
2022 324.45%
2021 -65.46%
2020 157.83%
2019 -20.48%
2018 -32.78%
2017 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$110.79 -14.38%
US
$347.16 -8.39%
US
$90.64 -2.45%
IE
$51.40 -49.85%
US
$92.95 19.66%
US